Otilimab
Otilimab is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against granulocyte-macrophage colony-stimulating factor.
| Trade Name | |
|---|---|
| Common Name | Otilimab |
| Indication | |
| Drug Class | Monoclonal antibodies: immunomodulating |
